Olivier Humblet

Regeneron Pharmaceuticals, Inc. Tarrytown, NY, USA

Poster(s):

• (SLB-022) Concordance between blinded independent central review committee and physician-assessed responses: Analyses based on a real-world external control arm in relapsed/refractory multiple myeloma using IMWG data
  Monday, August 25, 2025

  11:45 AM - 12:45 PM ET

• (C-153) Mind the Gap: a literature review to assess definitions of treatment discontinuation in oncology studies
  Tuesday, August 26, 2025

  12:00 PM - 1:30 PM ET

• (B-016) Trends in the Incidence of Monoclonal Gammopathy of Undetermined Significance (MGUS) Before and During the COVID-19 Pandemic
  Monday, August 25, 2025

  11:30 AM - 1:00 PM ET